Binder Gwendolyn — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Binder Gwendolyn has filed 1 SEC Form 4 filing across 1 company in the last 90 days — buying. Lifetime open-market purchases: $25K.

Profile

Gwendolyn Binder is listed as President, Science & Tech at Cabaletta Bio, Inc., a clinical-stage biotechnology company developing CAART cell therapies for B cell-mediated autoimmune diseases. In this role, she oversees Cabaletta's scientific and technological strategy and leads research and development efforts related to engineered T cell therapies.

Board memberships

• Cabaletta Bio, Inc.

Awards & honors

• Oversees scientific and technological strategy at Cabaletta Bio
• Leads development of CAART-engineered T cell therapies
• Guides research and development in autoimmune disease programs

Recent Transactions

Companies — Last 90 Days

• Instil Bio, Inc. (TIL) — 1 filings, last 2026-06-12

Frequently Asked Questions

Who is Binder Gwendolyn?

Gwendolyn Binder is listed as President, Science & Tech at Cabaletta Bio, Inc., a clinical-stage biotechnology company developing CAART cell therapies for B cell-mediated autoimmune diseases. In this role, she oversees Cabaletta's scientific and technological strategy and leads research and development efforts related to engineered T cell therapies.…

How many SEC Form 4 filings has Binder Gwendolyn submitted recently?

1 primary Form 4 filings in the last 90 days, covering 1 company.

Has Binder Gwendolyn been buying or selling stock?

Recorded transactions: 1 open-market purchases ($25K) and 0 open-market sales () across all tracked filings.

Where can I see all of Binder Gwendolyn's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

• What is SEC Form 4?
• How to read insider buying signals
• Understanding Rule 10b5-1 trading plans
• Browse all insiders
• Most active insiders this week